Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: The effect of gastric pH on double-peak phenomena

International Journal of Pharmaceutics

Volumn 255, Issue 1-2, 2003, Pages 81-86

  Mostafavi, S Abolfazl ^a,b   Foster, Robert T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acebutolol; Cimetidine; Double peaks; Interaction; Pharmacokinetics

Indexed keywords

ACEBUTOLOL; DIACETOLOL;

ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ADSORPTION; DRUG EFFECT; EVALUATION; FEEDING; JUGULAR VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STOMACH PH;

EID: 0037436947     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00037-1     Document Type: Article

References (39)

1. Bergstrom R.F., Kay D.R., Harkeson T.M., Wagner J.G. Penicillamine kinetics in normal subjects. Clin. Pharmacol. Ther. 30:1981;404-413.
2. Chatterji A.N. A randomized crossover comparison of acebutolol and methyldopa in the treatment of mild to moderate essential hypertension. Curr. Med. Res. 5:1978;675-681.
3. Christian C.D., Christian J.R., Meredith C.G., Speeg K.V. Cimetidine inhibits renal procainamide clearance. Clin. Pharmacol. Ther. 36:1984;221-227.
4. Clements J.A., Heading R.C., Nimmo W.S., Prescott L.F. Kinetics of acetaminophen absorption and gastric emptying in man. Clin. Pharmacokinet. 24:1978;420-431.
5. Fouvat B., Roux A., Chau N.P.et al. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol. Eur. J. Clin. Pharmacol. 19:1981;287-292.
6. Gradman A.H., Winkle R.A., Fitsgerald J.W., Meffin P.J., Stoner J.D., Bell P.A., Harrison D.C. Suppression of premature ventricular contractions by acebutolol. Circulation. 55:1977;785-791.
7. Grag D.C., Weidler D.J., Eshelman F.N. Ranitidine bioavailability and kinetics in normal male subjects. Clin. Pharmacol. Ther. 33:1983;445-452.
8. Gulaid A.A., James I.M., Kaye C.M., Lewellen O.R., Roberts R., Sankey M., Smith J., Templeton R., Thomas R.J. The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol as a single dose and during and after repeated oral dosing. Biopharm. Drug Dispos. 2:1981;103-114.
9. Hammarlund M.M., Palzow L.K., Odlind B. Pharmacokinetics of furosemide in man after intravenous and oral administration, Application of moment analysis. Eur. J. Clin. Pharmacol. 26:1984;197-207.
10. Hunt J.N., Knox M.T. The slowing of gastric emptying by four strong acids and three weak acids. J. Physiol. 222:1972;187-208.
11. Ioannoni B., Mason S.R., Reilly P.E., Winzor D.J. Evidence for induction of hepatic microsomal cytochrom P-450 by cimetidine: Binding and kinetic studies. Arch. Biochem. Biophys. 247:1986;372-383.
12. Meffin P.J., Winkle R.A., Peters F.A., Harrison D.C. Acebutolol disposition after intravenous administration. Clin. Pharmacol. Ther. 22(5pt.1):1977;557-567.
13. Meffin P.J., Winkle R.A., Peters F.A., Harrison D.C. Dose-dependent acebutolol disposition after oral administration. Clin. Pharmacol. Ther. 24:1978;542-547.
14. Mostafavi S.A., Foster R.T. Pharmacokinetics of single oral and multiple intravenous and oral administration of acebutolol enantiomers in a rat model. Biopharm. Drug Dispos. 19:1998;425-431.
15. Mostafavi S.A., Foster R.T. Pharmacokinetics of acebutolol enantiomers after iv. administration of racemate in a rat model: a dosing range comparison. Biopharm. Drug Dispos. 18:1997;397-408.
16. Mummaneni V., Amidon G.L., Dressman J.B. Gastric pH influences the appearance of double peaks in the plasma concentration-time profile of cimetidine after oral administration in dogs. Pharm. Res. 12:1995;780-786.
17. Nimmo W.S. Drugs, diseases and altered gastric emptying. Clin. Pharmacokinet. 1:1976;89-203.
18. Oberle C.Y., Amidon D. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets. J. Pharm. Sci. 75:1986;469-474.
19. 2 blockers and isoniazid. Eur. J. Respir. Dis. 68:1986;286-290.
20. Pederson P.V., Miller R. Pharmacokinetics and bioavailability of cimetidine in humans. J. Pharm. Sci. 69:1980;394-397.
21. Piquettee-Miller M., Jamali F. Multiple peaking of acebutolol enantiomers in the rat. Pharm. Res. 9(Suppl.):1992a;S-261.
22. Piquette-Miller M., Foster R.T., Pasutto F.M., Jamali F. Stereoselective high-performance liquid chromatographic assay of acebutolol in human plasma and urine. J. Chromatogr. 529:1990a;129-137.
23. Piquette-Miller M., Foster R.T. High-performance liquid chromatographic determination of diacetolol. J. Chromatogr. 533:1990b;300-303.
24. Piquette-Miller M., Foster R.T., Kappagoda C.T., Jamali F. Pharmacokinetics of acebutolol enantiomers in humans. J. Pharm. Sci. 80:1991;313-316.
25. Piquette-Miller M., Foster R.T., Kappagoda C.T., Jamali F. Effect of aging on the pharmacokinetics of acebutolol enantiomers. J. Clin. Pharm. 32:1992;148-156.
26. Piquette-Miller M., Jamali F. Effect of adjuvant arthritis on the disposition of Acebutolol enantiomers in rats. Agent Actions. 37:1992b;290-296.
27. Roux A., Aubert P., Gueden J., Flouvat B. Pharmacokinetics of acebutolol in patients with all grades of renal failure. Eur. J. Clin. Pharm. 17:1980;339-348.
28. Roux A., Flouvat B., Chau N.P., Letac B., Lucsko M. Pharmacokinetics of acebutolol after intravenous bolus administration. Br. J. Clin. Pharm. 9:1980;215-217.
29. Smout A.J., Jonkman J.H., Peeters P.A., De Bruin H. Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers. Aliment Pharmacol. Ther. 9:1995;51-56.
30. Singh B.N., Thoden W.R., Wahl J. Acebutolol: A review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects. Pharmacotherapy. 6:1986;45-63.
31. Somogyi A., Muirhead M. Pharmacokinetic interactions of cimetidine. Clin. Pharmacokinet. 12:1987;321-366.
32. 2-receptor antagonists on rat liver cytosolic acetyl CoA: arylamine N-acetyl transferase activity, vol. 20, pp. 74-78.
33. Thomson A.B., Kirdeikis P., Zuk L. Comparison of 200 mg cimetidine with multiple doses of antacid on extent and duration of rise in gastric pH in volunteers. Dig. Dis. Sci. 44:1999;2051-2055.
34. VanLiere E.J., Sleeth C.K. The emptying time of the normal human stomach as influenced by acid and alkali, with a review of the literature. AM J. Dig. Dis. 7:1940;118-123.
35. Walle T., Webb J.G., Bagwell E.E., Walle U.K., Daniell H.B., Gaffiney T.E. Stereoselective delivery and actions of beta receptor antagonists. Biochem. Pharmacol. 37:1988;115-124.
36. Winkle R.A., Meffin P.J., Ricks W.B., Harrison D.C. Acebutolol metabolite plasma concentration during chronic oral therapy. Br. J. Clin. Pharmacol. 4:1977;519-522.
37. Wright A.W., Winzor D.J., Reilly P.E. Cimetidine: an inhibitor and an inducer of rat liver microsomal cytochrome P-450. Xenobiotica. 21:1991;193-203.
38. Zaman R., Jack D.B., Wilkins M.R., Kendall M.J. Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study. Biopharm Drug Dispos. 6:1985;131-137.
39. Zaman R., Wilkins M.R., Kendall M.J., Jack D.B. The effect of food and alcohol on the pharmacokinetics of acebutolol and its metabolite diacetolol. Biopharm Drug Dispos. 5:1984;91-95.